BridgeMD
New treatment option for Colorectal Cancer Screening
Official title Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
ClinicalTrials.gov ID: NCT06745895
What this study is testing
- What it's testing
- This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Participants must be receiving care at one of the participating FQHC clinics.
- Participants must be 45-75 years of age.
- Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood...
- Participants must never have had Hepatitis C Virus (HCV) antibody screening.
- Participants must be able to read, write, and understand English or Spanish.
You likely can't join if
- Participants that do not meet all Inclusion Eligibility requirements will be excluded.
See the full eligibility criteria
- Participants must be receiving care at one of the participating FQHC clinics.
- Participants must be 45-75 years of age.
- Participants must not be up to date with Colorectal Cancer (CRC) screening recommendations such as no colonoscopy in the past 10 years, occult blood test in the past 12 months.
- Participants must never have had Hepatitis C Virus (HCV) antibody screening.
- Participants must be able to read, write, and understand English or Spanish.
- Participants must have no personal history of CRC or current presumptive CRC symptoms such as unresolved rectal bleeding or abdominal pain/bloating.
- Participants must be at average risk for CRC (no hereditary CRC syndromes such as lower gastrointestinal (GI) bleeding, persistent diarrhea, bloating, or lower GI pain, no strong family history of CRC).
- Participants must be asymptomatic for HCV.
- Participants receiving intervention materials must be able and willing to complete surveys and receive the patient level intervention.
- Participants completing qualitative interviews must be willing to complete a remote interview via phone or teleconference software such as ZOOM.
- Participants completing qualitative interviews must be willing to be audio recorded.
- Participants recruited for qualitative interviews only (did not receive MATCHES intervention materials) must have a clinic visit within prior two months.
- All Participants must be able to provide informed consent.
- Participants that do not meet all Inclusion Eligibility requirements will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Tampa, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tampa, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.